Protego Biopharma

Developer of small molecule therapeutics platform designed to reprogram protein folding for the treatment of various systemic amyloid diseases and protein misfolding diseases. The company's drug discovery platform in order to address the protein misfolding problem modulates the energetics of proteins using pharmacological chaperones and/or modulates the cellular folding, secretory, and stress pathways, enabling doctors to obtain disease-modifying therapeutics.

Lightspeed

🏥 Healthcare